220 related articles for article (PubMed ID: 9774648)
21. Monoclonal antibodies raised against Xenopus p53 interact with human p73.
Le Bras M; Delattre V; Bensaad K; Blandino G; Soussi T
Oncogene; 2002 Feb; 21(8):1304-8. PubMed ID: 11850851
[TBL] [Abstract][Full Text] [Related]
22. p73beta, unlike p53, suppresses growth and induces apoptosis of human papillomavirus E6-expressing cancer cells.
Prabhu NS; Somasundaram K; Satyamoorthy K; Herlyn M; El-Deiry WS
Int J Oncol; 1998 Jul; 13(1):5-9. PubMed ID: 9625796
[TBL] [Abstract][Full Text] [Related]
23. MDM2 and MDMX bind and stabilize the p53-related protein p73.
Ongkeko WM; Wang XQ; Siu WY; Lau AW; Yamashita K; Harris AL; Cox LS; Poon RY
Curr Biol; 1999 Jul 29-Aug 12; 9(15):829-32. PubMed ID: 10469568
[TBL] [Abstract][Full Text] [Related]
24. p73 cooperates with DNA damage agents to induce apoptosis in MCF7 cells in a p53-dependent manner.
Zhu J; Nozell S; Wang J; Jiang J; Zhou W; Chen X
Oncogene; 2001 Jul; 20(30):4050-7. PubMed ID: 11494133
[TBL] [Abstract][Full Text] [Related]
25. Targeting of p53 and its homolog p73 by protoporphyrin IX.
Sznarkowska A; Maleńczyk K; Kadziński L; Bielawski KP; Banecki B; Zawacka-Pankau J
FEBS Lett; 2011 Jan; 585(1):255-60. PubMed ID: 21146529
[TBL] [Abstract][Full Text] [Related]
26. Mdm2 binds p73 alpha without targeting degradation.
Bálint E; Bates S; Vousden KH
Oncogene; 1999 Jul; 18(27):3923-9. PubMed ID: 10435614
[TBL] [Abstract][Full Text] [Related]
27. p73 competes with p53 and attenuates its response in a human ovarian cancer cell line.
Vikhanskaya F; D'Incalci M; Broggini M
Nucleic Acids Res; 2000 Jan; 28(2):513-9. PubMed ID: 10606650
[TBL] [Abstract][Full Text] [Related]
28. Promoter specificity and stability control of the p53-related protein p73.
Lee CW; La Thangue NB
Oncogene; 1999 Jul; 18(29):4171-81. PubMed ID: 10435630
[TBL] [Abstract][Full Text] [Related]
29. Role of p73 in malignancy: tumor suppressor or oncogene?
Stiewe T; Pützer BM
Cell Death Differ; 2002 Mar; 9(3):237-45. PubMed ID: 11859406
[TBL] [Abstract][Full Text] [Related]
30. Failure of viral oncoproteins to target the p53-homologue p51A.
Roth J; Dobbelstein M
J Gen Virol; 1999 Dec; 80 ( Pt 12)():3251-3255. PubMed ID: 10567658
[TBL] [Abstract][Full Text] [Related]
31. Subcellular distribution of p53 and p73 are differentially regulated by MDM2.
Gu J; Nie L; Kawai H; Yuan ZM
Cancer Res; 2001 Sep; 61(18):6703-7. PubMed ID: 11559539
[TBL] [Abstract][Full Text] [Related]
32. p73 and p63 are homotetramers capable of weak heterotypic interactions with each other but not with p53.
Davison TS; Vagner C; Kaghad M; Ayed A; Caput D; Arrowsmith CH
J Biol Chem; 1999 Jun; 274(26):18709-14. PubMed ID: 10373484
[TBL] [Abstract][Full Text] [Related]
33. Physical and functional interaction between p53 mutants and different isoforms of p73.
Strano S; Munarriz E; Rossi M; Cristofanelli B; Shaul Y; Castagnoli L; Levine AJ; Sacchi A; Cesareni G; Oren M; Blandino G
J Biol Chem; 2000 Sep; 275(38):29503-12. PubMed ID: 10884390
[TBL] [Abstract][Full Text] [Related]
34. Specific isoforms of p73 control the induction of cell death induced by the viral proteins, E1A or apoptin.
Klanrit P; Flinterman MB; Odell EW; Melino G; Killick R; Norris JS; Tavassoli M
Cell Cycle; 2008 Jan; 7(2):205-15. PubMed ID: 18256531
[TBL] [Abstract][Full Text] [Related]
35. The tumor suppressor protein p53 functions similarly to p63 and p73 in activating transcription in vitro.
Mondal N; Parvin JD
Cancer Biol Ther; 2005 Apr; 4(4):414-8. PubMed ID: 15846087
[TBL] [Abstract][Full Text] [Related]
36. MDM2 and MDMX can interact differently with ARF and members of the p53 family.
Wang X; Arooz T; Siu WY; Chiu CH; Lau A; Yamashita K; Poon RY
FEBS Lett; 2001 Feb; 490(3):202-8. PubMed ID: 11223036
[TBL] [Abstract][Full Text] [Related]
37. Family members p53 and p73 act together in chromatin modification and direct repression of alpha-fetoprotein transcription.
Cui R; Nguyen TT; Taube JH; Stratton SA; Feuerman MH; Barton MC
J Biol Chem; 2005 Nov; 280(47):39152-60. PubMed ID: 16203738
[TBL] [Abstract][Full Text] [Related]
38. Relief of p53-mediated telomerase suppression by p73.
Toh WH; Kyo S; Sabapathy K
J Biol Chem; 2005 Apr; 280(17):17329-38. PubMed ID: 15734740
[TBL] [Abstract][Full Text] [Related]
39. Skin human papillomavirus type 38 alters p53 functions by accumulation of deltaNp73.
Accardi R; Dong W; Smet A; Cui R; Hautefeuille A; Gabet AS; Sylla BS; Gissmann L; Hainaut P; Tommasino M
EMBO Rep; 2006 Mar; 7(3):334-40. PubMed ID: 16397624
[TBL] [Abstract][Full Text] [Related]
40. p73 beta-expressing recombinant adenovirus: a potential anticancer agent.
Das S; Nama S; Antony S; Somasundaram K
Cancer Gene Ther; 2005 Apr; 12(4):417-26. PubMed ID: 15678153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
